Emotional disclosure interventions for chronic pain: From the laboratory to the clinic

Translational Behavioral Medicine

Volumn 2, Issue 1, 2012, Pages 73-81

  Lumley, Mark A ^a   Sklar, Elyse R ^a   Carty, Jennifer N ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic pain; Emotional disclosure; Expressive writing; Stress; Translational research

Indexed keywords

GAMMA INTERFERON; HYDROCORTISONE; INTERLEUKIN 6;

ABDOMINAL PAIN; CANCER PAIN; CHRONIC PAIN; CLINICAL PRACTICE; COGNITIVE THERAPY; DISEASE ACTIVITY; EMOTION; ERYTHROCYTE SEDIMENTATION RATE; FIBROMYALGIA; HEADACHE; HUMAN; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHEUMATOID ARTHRITIS; SLEEP QUALITY;

EID: 84858727795     PISSN: 18696716     EISSN: 16139860     Source Type: Journal    
DOI: 10.1007/s13142-011-0085-4     Document Type: Review

References (60)

1. Lumley M, Cohen J, Borszcz G, et al. Pain and emotion: a biopsychosocial review of recent research. J Clin Psychol. 2011; 67: 1-27.
2. Davis DA, Luecken LJ, Zautra AJ. Are reports of childhood abuse related to the experience of chronic pain in adulthood? A meta-analytic review of the literature. Clin J Pain. 2005; 21(5): 398-405.
3. Imbierowicz K, Egle UT. Childhood adversities in patients with fibromyalgia and somatoform pain disorder. Eur J Pain. 2003; 7: 113-119.
4. Latthe P, Mignini L, Gray R, Hills R, Khan K. Factors predisposing women to chronic pelvic pain: systematic review. BMJ. 2006; 332: 749-755.
5. Sumanen M, Rantala A, Sillanmäki LH, Mattila KJ. Childhood adversities experienced by working-age migraine patients. J Psychosom Res. 2007; 62: 139-143.
6. Davis MC, Zautra AJ, Reich JW. Vulnerability to stress among women in chronic pain from fibromyalgia and osteoarthritis. Ann Behav Med. 2001; 23: 215-226.
7. Eisenberger NI, Jarcho JM, Lieberman MD, Naliboff BD. An experimental study of shared sensitivity to physical pain and social rejection. Pain. 2006; 126: 132-138.
8. Kivimaki M, Leino-Arjas P, Virtanen M, et al. Work stress and incidence of newly diagnosed fibromyalgia prospective cohort study. J Psychosom Res. 2004; 57: 417-422.
9. Rhudy JL, Williams AE, McCabe KM, Russell JL, Maynard LJ. Emotional control of nociceptive reactions (ECON): do affective valence and arousal play a role? Pain. 2008; 136: 250-261.
10. Lumley MA. The two views of emotion in psychosomatic research. J Psychosom Res. 2010; 68: 219-221.
11. Davis MC, Zautra AJ, Smith BW. Chronic pain, stress, and the dynamics of affective differentiation. J Personal. 2004; 72: 1133-1160.
12. Hayes SC, Wilson KG, Gifford EV, Follette VM, Strosahl K. Experimental avoidance and behavioral disorders: a functional dimensional approach to diagnosis and treatment. J Consult Clin Psychol. 1996; 64: 1152-1168.
13. Lane RD, Waldstein SR, Critchley HD, et al. The rebirth of neuroscience in psychosomatic medicine, part II: clinical applications and implications for research. Psychosom Med. 2009; 71: 135-151.
14. van Houdenhove B, Egle U, Luyten P. The role of life stress in fibromyalgia. Curr Rheumatol Rep. 2005; 7: 365-370.
15. Carson JW, Keefe FJ, Lowrey KP, Porter LS, Goli V, Fras AM. Conflict about expressing emotions and chronic low back pain: associations with pain and anger. J Pain. 2007; 8: 405-411.
16. Porter LS, Keefe FJ, Lipkus I, Hurwitz H. Ambivalence over emotional expression in patients with gastrointestinal cancer and their caregivers: associations with patient pain and quality of life. Pain. 2005; 117: 340-348.
17. van Middendorp H, Lumley MA, Jacobs JWG, van Doornen LJP, Bijlsma JWJ, Geenen R. Emotions and emotional approach and avoidance strategies in fibromyalgia. J Psychosom Res. 2008; 64: 159-167.
18. Wenzlaff RM. Wegner DM thought suppression. Annu Rev Psychol. 2000; 51: 59-91.
19. Gross JJ. Emotion regulation: affective, cognitive, and social consequences. Psychophysiology. 2002; 39: 281-291.
20. Burns JW, Quartana PJ, Bruehl S. Anger inhibition and pain: conceptualizations, evidence and new directions. J Behav Med. 2008; 31: 259-279.
21. Burns JW, Quartana P, Gilliam W, et al. Effects of anger suppression on pain severity and pain behaviors among chronic pain patients: evaluation of an ironic process model. Heal Psychol. 2008; 27: 645-652.
22. Kearns R, Selligner J, Goodin B. Psychological treatment of chronic pain. Annu Rev Clin Psychol. 2011; 7: 411-434.
23. Barlow D, Lehman C. Advances in the psychosocial treatment of anxiety disorders. Implications for national health care. Arch Gen Psychiatry. 1996; 53: 727-735.
24. Foa E, Kozak M. Emotional processing of fear: exposure to corrective information. Psychol Bull. 1986; 99: 20-35.
25. Pennebaker JW, Barger SD, Tiebout J. Disclosure of traumas and health among holocaust survivors. Psychosom Med. 1989; 51: 577-589.
26. Pennebaker JW, O'Heeron RC. Confiding in others and illness rate among spouses of suicide and accidental-death victims. J Abnorm Psychol. 1984; 93: 473-476.
27. Pennebaker J, Beall S. Confronting a traumatic event: toward an understanding of inhibition and disease. J Abnorm Psychol. 1986; 95: 274-281.
28. Smyth JM. Written emotional expression: effect sizes, outcome types, and moderating variables. J Consult Clin Psychol. 1998; 66: 174-184.
29. Smyth J, Stone A, Hurewitz A, Kaell A. Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis, a randomized trial. JAMA. 1999; 281: 1304-1309.
30. Stone AA, Smyth JM, Kaell A, Hurewitz A. Structured writing about stressful events: exploring potential psychological mediators of positive health effects. Heal Psychol. 2000; 19: 619-624.
31. Broderick J, Stone A, Smyth J, Kaell A. The feasibility and effectiveness of an expressive writing intervention for rheumatoid arthritis via home-based videotaped instructions. Ann Behav Med. 2004; 27: 50-59.
32. Kelley JE, Lumley MA, Leisen JCC. Health effects of emotional disclosure in rheumatoid arthritis patients. Heal Psychol. 1997; 16: 331-340.
33. Lumley M, Leisen J, Partridge R, et al. Does emotional disclosure about stress improve health in rheumatoid arthritis? Randomized, controlled trials of written and spoken disclosure. Pain. 2011; 152: 866-877.
34. Wetherell M, Byrne-Davis L, Dieppe P, et al. Effects of emotional disclosure on psychological and physiological outcomes in patients with rheumatoid arthritis: an exploratory home-based study. J Heal Psychol. 2005; 10: 277-285.
35. van Middendorp H, Geenen R, Sorbi MJ, van Doornen LJP, Bijlsma JWJ. Health and physiological effects of an emotional disclosure intervention adapted for application at home: a randomized clinical trial in rheumatoid arthritis. Psychother Psychosom. 2009; 78: 145-151.
36. van Middendorp H, Geenen R. Poor cognitive-emotional processing may impeded the outcome of emotional disclosure interventions. Br J Heal Psychol. 2008; 13: 49-52.
37. Danoff-Burg S, Agee J, Romanoff N, Kremer J, Stronsberg J. Benefit finding and expressive writing in adults with lupus or rheumatoid arthritis. Psychol Heal. 2006; 21: 651-665.
38. Keefe F, Anderson T, Lumley M, et al. A randomized, controlled trial of emotional disclosure in rheumatoid arthritis: can clinician assistance enhance the effects? Pain. 2008; 137: 164-172.
39. Gillis M, Lumley M, Mosley-Williams A, Leisen J, Roehrs T. The health effects of at-home written emotional disclosure in fibromyalgia: a randomized trial. Ann Behav Med. 2006; 32: 135-146.
40. Broderick JE, Junghaenel DU, Schwartz JE. Written emotional expression produces health benefits in fibromyalgia patients. Psychosom Med. 2005; 67: 326-334.
41. Junghaenel D, Schwartz J, Broderick J. Differential efficacy of written emotional disclosure for subgroups of fibromyalgia patients. Br J Heal Psychol. 2009; 13: 57-60.
42. Wallander JL, Madan-Swain A, Klapow J, Saeed S. A randomised controlled trial of written self-disclosure for functional recurrent abdominal pain in youth. Psychol Heal. 2011; 26: 433-447.
43. D'Souza PJ, Lumley MA, Kraft CA, Dooley JA. Relaxation training and written emotional disclosure for tension or migraine headaches: a randomized, controlled trial. Ann Behav Med. 2008; 36: 21-32.
44. Kraft CA, Lumley MA, D'Souza PJ, Dooley JA. Emotional approach coping and self-efficacy moderate the effects of written emotional disclosure and relaxation training for people with migraine headaches. Br J Heal Psychol. 2008; 13: 67-71.
45. Graham J, Lobel M, Glass P, Lokshina I. Effects of written anger expression in chronic pain patients: making meaning from pain. J Behav Med. 2008; 31: 201-212.
46. Norman SA, Lumley MA, Dooley JA, Diamond MP. For whom does it work? Moderators of the effects of written emotional disclosure in a randomized trial among women with chronic pelvic pain. Psychosom Med. 2004; 66: 174-183.
47. Cepeda MS, Chapman R, Miranda N, et al. Emotional disclosure through patient narrative may improve pain and well-being: results of a randomized controlled trial in patients with cancer pain. J Pain Symptom Manag. 2008; 35: 623-631.
48. Freyd JJ, Klest B, Allard CB. Betrayal trauma: relationship to physical health, psychological distress, and a written disclosure intervention. J Trauma Dissociation. 2005; 6: 83-104.
49. Frisina PG, Borod JC, Lepore S. A meta-analysis of the effects of written emotional disclosure on the health outcomes of clinical populations. J Nerv Ment Dis. 2004; 192: 629-634.
50. Frattaroli J. Experimental disclosure and its moderators: a meta-analysis. Psychol Bull. 2006; 132: 823-865.
51. Harris AH. Does expressive writing reduce health care utilization? A meta-analysis of randomized trials. J Consult Clin Psychol. 2006; 74: 243-252.
52. Lumley M, Tojek T, Macklem D. The effects of written emotional disclosure among repressive and alexithymic people. In: Lepore SJ, Smyth JM, eds. The writing cure: how expressive writing promotes health and emotional well-being. Washington, DC: American Psychological Association; 2002: 75-95.
53. Solano L, Donati V, Pecci F, Persichetti S, Colaci A. Postoperative course after papilloma resection: effects of written disclosure of the experience in subjects with different alexithymia levels. Psychosom Med. 2003; 65: 477-484.
54. Zakowski SG, Ramati A, Morton C, Johnson P, Flanigan R. Written emotional disclosure buffers the effects of social constraints on distress among cancer patients. Heal Psychol. 2004; 23: 555-563.
55. Walker E, Keegan D, Gardner G, et al. Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: II. Sexual, physical, and emotional abuse and neglect. Psychosom Med. 1997; 59: 572-577.
56. Brosschot JF, Aarsse HR. Restricted emotional processing and somatic attribution in fibromyalgia. Int J Psychiatr Med. 2001; 31: 127-146.
57. Byrne-Davis L, Wetherell M, Dieppe P, et al. Emotional disclosure in rheumatoid arthritis: participants' views on mechanisms. Psychol Heal. 2006; 21: 667-682.
58. Smyth JM, Catley D. Translating research into practice: potential of expressive writing in the field. In: Lepore SJ, Smyth JM, eds. The writing cure: how expressive writing promotes health and emotional well-being. Washington, DC: American Psychological Association; 2002: 199-214.
59. Nazarian D, Smyth JM. Context moderates the effects of an expressive writing intervention: a randomized two-study replication and extension. J Soc Clin Psychol. 2010; 29: 903-929.
60. Radcliffe A, Lumley M, Kendall J, Stevenson J, Beltran J. Written emotional disclosure: testing whether social disclosure matters. J Soc Clin Psychol. 2007; 26: 362-384.